The current status of treatment in the elderly differentiated thyroid cancer
10.3760/cma.j.issn.1008-1372.2017.12.053
- VernacularTitle:老年分化型甲状腺癌的治疗现状
- Author:
Yi XIE
1
;
Wei ZHENG
Author Information
1. 湖南省人民医院乳甲外科
- Keywords:
Thyroid neoplasms/TH;
Review
- From:
Journal of Chinese Physician
2017;19(12):1916-1918
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of differentiated thyroid carcinoma ( DTC) has increased in all age groups worldwide. Most patients with DTC have a good prognosis, but older patients have a poor prognosis because of high invasiveness and disease-specific mortality. At present, DTC treatment mainly includes surgery, thy-roid stimulating hormone ( TSH) inhibition , radioiodine ( 131 I) , external radiotherapy, and kinase inhibi-tors ( KIs) . Elderly patients with thyroid cancer might have many treatment-related complications due to dis-ease and their own reasons. This review uses the risk-benefit approach to weigh the pros and cons of various treatments to determine the most reasonable management.